Form 4: U.S. Physical Therapy Director Kathleen Gilmartin Reports Acquisition of Restricted Stock

Sentiment:

SEC Form 4 Filing


Kathleen Gilmartin, a director of U.S. Physical Therapy, reported the acquisition of 1,882 shares of restricted stock on May 20, 2025.

Summary

  • On May 20, 2025, Kathleen Gilmartin, a director of U.S. Physical Therapy Inc., acquired 1,882 shares of common stock.
  • These shares were granted as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan.
  • The restrictions on these shares will lapse in three tranches: 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, contingent on her continued service as a director.
  • Following this transaction, Gilmartin directly owns 20,786 shares of U.S. Physical Therapy Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring more stock generally indicates confidence in the company's future, but it's a routine transaction.

Positives

  • The acquisition of restricted stock by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock is contingent on Kathleen Gilmartin's continued service as a director.

Industry Context

Director stock acquisitions are common in publicly traded companies and are often seen as a positive sign of alignment between management and shareholder interests. This filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

  • Stock ownership by directors is a common practice across the healthcare and physical therapy industry.
  • Comparing Gilmartin's holdings to those of directors at companies like ATI Physical Therapy or Select Medical Holdings would provide a benchmark for assessing her level of investment in U.S. Physical Therapy relative to peers.
  • The vesting schedule of the restricted stock is fairly standard, with restrictions lapsing over a period of months or years contingent on continued service.

Stakeholder Impact

  • Shareholders may view the director's stock acquisition as a positive signal.
  • The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
February 25, 2025Date of Power of Attorney execution by Kathleen Gilmartin.
May 20, 2025Date of transaction: Kathleen Gilmartin acquired 1,882 shares of restricted stock.
May 21, 2025Date of signature of the Form 4 filing.
August 20, 2025Date restrictions lapse on 941 shares.
November 20, 2025Date restrictions lapse on 470 shares.
March 6, 2026Date restrictions lapse on 471 shares.

Keywords

U.S. Physical Therapy, Director, Kathleen Gilmartin, Restricted Stock, Beneficial Ownership, Form 4, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.